We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers

By LabMedica International staff writers
Posted on 31 Jul 2018
Sekisui Diagnostics (Lexington, MA, USA) showcased its clinical chemistry and immunoassay analyzers, including the SK500 clinical chemistry system and FastPack IP System, at the 70th Annual Scientific Meeting & Clinical Lab Expo held by the American Association for Clinical Chemistry (AACC) on July 29 – August 2, 2018 in Chicago, USA. More...
AACC is the largest global scientific conference and tradeshow in laboratory medicine, with ~20,000 attendees and 750 exhibitors from around the world. AACC 2018 also provided Plenary Sessions featuring world-renowned scientists and scientific sessions covering a broad range of subjects at various experience levels, and focused “Brown Bag” sessions that gave attendees the opportunity to pose questions in small groups.

Sekisui Diagnostics provides diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. The company’s product lines include clinical chemistry systems and reagents, coagulation systems and reagents, point of care rapid tests and immunoassay system, enzymes and specialty biochemical.

The SK500 Clinical Chemistry System showcased by Sekisui Diagnostics at AACC 2018 is a compact and efficient instrument with a full menu of high quality reagents specifically designed and packaged for the system, including the addition of a drugs of abuse testing menu. Sekisui Diagnostics also showcased the FastPack IP System, a fully automated quantitative immunoassay analyzer which uses sophisticated chemiluminescence technology to deliver accurate test results for commonly ordered tests in 12 minutes or less with a push of a button.

Also featured at the event was the company’s recently launched Silaris Influenza A&B Test which utilizes an affordable, polymerase chain reaction (PCR) testing platform specifically for point of care infectious disease diagnosis. It offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of laboratory-based PCR testing.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.